EichorEICHOR
Location: Clovis Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Clovis

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav
Phase 3 · Clovis Community Medical Center · Pfizer · NCT05020236A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Community Cancer Institute (CCI) · Hoffmann-La Roche · NCT06793215Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Phase 3 · University of California, Fresno · Kura Oncology, Inc. · NCT07007312RA-PRO PRAGMATIC TRIAL
Phase 3 · Dr. Jayashree Sinha · University of Alabama at Birmingham · NCT04692493A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Dar
Phase 3 · UCSF Fresno · Janssen Research & Development, LLC · NCT05552222Improving Survivorship Care for Older Adults After Chemotherapy
NA · Community Cancer Institute · University of California, San Francisco · NCT04405115MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Ha
Phase 3 · Clovis Community Medical Center · Pfizer · NCT06152575A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Phase 3 · Community Cancer Institute ( Site 0100) · Merck Sharp & Dohme LLC · NCT06966700Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed
Phase 3 · Community Health Partners (CHP) - Community Medical Oncology · Sanofi · NCT07007962Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure
Phase 2 · UCSF-Fresno · Brian Jonas · NCT04905810Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabo
Phase 2 · Community Cancer Institute · National Cancer Institute (NCI) · NCT03866382A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Phase 3 · Research Site · AstraZeneca · NCT06549595To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
Phase 3 · University of California, San Francisco Fresno · Acrotech Biopharma Inc. · NCT06072131Fertilo In Vitro Research Study and Trial
Phase 3 · Women's Specialty & Fertility Center · Gameto, Inc. · NCT06858111Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Neg
Phase 3 · Community Cancer Institute · Gilead Sciences · NCT05633654A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combinatio
Phase 3 · UCSF FRESNO/Community Cancer Institute /ID# 270874 · AbbVie · NCT06428019Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, o
Phase 2 · Community Cancer Institute · National Cancer Institute (NCI) · NCT03739814A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer
Phase 3 · Community Cancer Institute · Eli Lilly and Company · NCT07174336Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Phase 3 · Community Cancer Institute · SWOG Cancer Research Network · NCT03678025Efficacy of M640 in Acute Lumbosacral Musculoskeletal Conditions.
Phase 4 · Jayashree Sinha, MD 1 · Primus Pharmaceuticals · NCT06157177A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Phase 1/Phase 2 · Community Cancer Institute · Bristol-Myers Squibb · NCT04895709A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcita
Phase 2 · Community Cancer Institute (CCI) · Hoffmann-La Roche · NCT06806033Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leu
Phase 3 · Community Cancer Institute · Alliance for Clinical Trials in Oncology · NCT03150693
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.